Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction - Wikidata - awgldk - TriplyDB

Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction

Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction

http://www.wikidata.org/entity/Q37258096

about

Proteomics for rejection diagnosis in renal transplant patients: Where are we now?Applications of urinary proteomics in biomarker discovery Proteomics and metabolomics in renal transplantation-quo vadis?Relative quantitation of neuropeptides over a thousand-fold concentration range.Targeted quantitative phosphoproteomic analysis of erythrocyte membranes during blood bank storage.Proteomic signatures in plasma during early acute renal allograft rejection Label-free proteomics reveals decreased expression of CD18 and AKNA in peripheral CD4+ T cells from patients with Vogt-Koyanagi-Harada syndrome Label-free quantitation of phosphopeptide changes in erythrocyte membranes: towards molecular mechanisms underlying deformability alterations in stored red blood cells.Biomarkers in renal transplantation: An updated review.Shotgun proteomics identifies proteins specific for acute renal transplant rejection.Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases.Analysis of the differentially expressed low molecular weight peptides in human serum via an N-terminal isotope labeling technique combining nano-liquid chromatography/matrix-assisted laser desorption/ionization mass spectrometry.Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS.Mechanistic peptidomics: factors that dictate specificity in the formation of endogenous peptides in human milk.Investigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics.Current peptidomics: applications, purification, identification, quantification, and functional analysis Difference gel electrophoresis identifies differentially expressed proteins in endoscopically collected pancreatic fluid Investigating endogenous peptides and peptidases using peptidomics Profiling protease activities by dynamic proteomics workflows.Elevated expression levels of ANXA11, integrins β3 and α3, and TNF-α contribute to a candidate proteomic signature in urine for kidney allograft rejection.An Optimized Informatics Pipeline for Mass Spectrometry-Based Peptidomics.Urinary Kininogen-1 and Retinol binding protein-4 respond to Acute Kidney Injury: predictors of patient prognosis?Quantitation of endogenous peptides using mass spectrometry based methods.Biological signalling activity measurements using mass spectrometry.Profiling the proteome in renal transplantation.Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS.High-Throughput Proteomic Approaches to the Elucidation of Potential Biomarkers of Chronic Allograft Injury (CAI).Current status and advances in quantitative proteomic mass spectrometry.Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.Biomarkers that predict diabetic nephropathy: the long road from finding targets to clinical use.Urinary peptidomics in kidney disease and drug research.Development of a label-free LC-MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy.A stable panel comprising 18 urinary proteins in the human healthy population.Nucleoid-enriched proteomes in developing plastids and chloroplasts from maize leaves: a new conceptual framework for nucleoid functions.Structural and metabolic transitions of C4 leaf development and differentiation defined by microscopy and quantitative proteomics in maize.

P2860

Q26751478-CFF2B0CB-08E0-42AC-96A5-39E328F7EB9D Q27010368-1CC7D2AF-1E5A-4610-8BA7-D215BBAEB6B9 Q27024418-C1907ECD-A88C-46EA-A9A6-398482A7D189 Q31095533-34570C18-C39C-4FD7-9BE0-E7A262CDC3DD Q33457255-1EA171E4-F79D-4C7D-AFEE-8B47960C438B Q33587191-DF532BF9-4E52-4285-9F5C-1B714AD9C0A5 Q33812988-71B90B19-E192-4DB1-96EE-8BAD8E2B2445 Q33828616-1BAB0CCC-3CDB-4B7E-B956-86BFB0AFBFA4 Q33842783-388196D1-8556-4368-8F0E-1C7279A36510 Q33903986-455ECF15-5766-4516-B387-0CB91C6CB091 Q34187912-D7ED16B4-E715-4C83-B5F9-47EEAC16177E Q34420715-2D433B63-40F4-4801-B662-7CE33F337A4C Q34571042-4AA82109-AC7A-4173-91C4-6ACB4E9FC23E Q34634913-D7CDA059-BB47-4230-8BC0-568786DDB754 Q35049696-FC974B2A-71A4-4C37-83DC-3E9CE166270E Q35212347-B3FB690B-BB96-4176-8694-6CD83E6F70E6 Q36029032-66FEE94E-D934-4DF8-AD8E-6A5016ADF091 Q36163374-CC2C2FE8-20F2-4F0F-ACBF-B60E8458D741 Q36199807-DE933F72-F417-4C39-A684-DE0075EF3A9F Q36241222-5FE51ADD-0D61-4416-94FC-5494C1EED0A5 Q36305003-CBD0A0A6-EBF1-42ED-BFD8-4D2E1F8E45C9 Q36500448-7E20B5AC-8819-4506-8713-DA43DFE7CAC6 Q37257611-C8F8900C-A050-4F67-80EC-078CC85BD577 Q37839120-1D83E488-06F4-4BE5-9C11-17B90839F808 Q37869065-CF8E39F9-552F-4B24-A7DB-9E48A2B1CF9B Q38502483-D1983FAF-B245-42FD-813D-39D3BAC60770 Q38934802-6FFA8BF5-F1CB-4CAE-854B-DE5E6C2633D1 Q39246192-E8E13E7F-BB39-4906-9717-561FAA326196 Q39732824-937C4671-972E-4A2C-BAAF-0BEAB7CFCBCB Q41534193-29A87531-669C-48A6-AC6B-6544FB8C9033 Q47781932-01EE1435-73CE-4CFC-BA09-B1ACDEB2A07B Q50996571-DEFA8E6A-E508-4AAC-9121-0BB5F24ED06F Q51344954-B1641951-C12D-49F0-870D-9C64A34414D1 Q51848166-3197847C-0DD1-4C5B-8459-C86C4941EFB2 Q51895579-148B010B-7510-4C36-A1CA-077A607CD23D

P2860

Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction

http://www.wikidata.org/entity/Q37258096

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Application of label-free quan ...... chronic allograft dysfunction

@en

Application of label-free quan ...... chronic allograft dysfunction.

@nl

type

label

Application of label-free quan ...... chronic allograft dysfunction

@en

Application of label-free quan ...... chronic allograft dysfunction.

@nl

prefLabel

Application of label-free quan ...... chronic allograft dysfunction

@en

Application of label-free quan ...... chronic allograft dysfunction.

@nl

P1433

Q37258096-40210B2F-C33C-4DF2-B09C-9B161310AC52

P1476

Q37258096-2E64CFC1-DDD6-4214-9BDB-63126A67822D

P2093

Q37258096-038239B8-3298-4545-A709-F91721B6AD7A

Q37258096-5A38B9E3-99A3-4122-A6B1-1ECEA4F01F34

Q37258096-822EE03D-66EA-42A3-84B5-0C2F07C856C8

Q37258096-971F4DCB-42C4-4E18-9976-89A04202C151

Q37258096-D0DF8F1A-2065-4A6D-82F8-1003860CC467

Q37258096-DB6F46B3-C271-41E8-B104-0E7488E3FF39

P2860

Q37258096-0A843708-99D2-4686-B058-35A702C614EE

Q37258096-0BF05731-45D4-4181-89F1-3FD7A80DBD85

Q37258096-0C94929E-1C83-4870-93E5-50375709E671

Q37258096-0DDC1C7C-C391-4C94-92BF-E5AF1EC6A375

Q37258096-0F977AB7-2F01-4299-80BD-287DD9596D8E

Q37258096-2183A899-EF95-4E34-904D-54C0FEEE6923

Q37258096-2BFD92BF-58BC-467A-BBC4-33CE7C4EEB87

Q37258096-2E7B2088-4C09-4E71-8F38-2E7D7045008A

Q37258096-2EACABF6-38E2-4997-A751-DF19BD1F4086

Q37258096-35523267-646E-4782-ACF0-856C5F7A5EE8

P304

Q37258096-49165DE0-966D-42A5-ABCF-609EBBC717F5

P31

Q37258096-0475D3E9-D20A-4247-BBB0-638E35486DBE

P356

Q37258096-C4A22642-8F29-4224-8E42-7BD40A6DF3A6

P433

Q37258096-1E7571CE-4470-4879-A27E-E7C1F0591F64

P478

Q37258096-781A2E40-8108-46FB-A381-D15758CEA07D

P577

Q37258096-7A8727C7-4291-46E3-B814-D0699ACFE331

P698

Q37258096-1AD15FB2-6429-4787-8847-EB32EB162568

P921

Q37258096-EC126326-41DC-40EE-B446-65211DEC9427

P932

Q37258096-74258439-D4AB-499B-A935-C97CD4021267

P356

MCP.M900059-MCP200

P1433

Molecular & Cellular Proteomics

P1476

Application of label-free quan ...... chronic allograft dysfunction

@en

P2093

Amandaé Sol-González

http://www.w3.org/2001/XMLSchema#string

Elisenda Bañon-Maneus

http://www.w3.org/2001/XMLSchema#string

Josep M Campistol

http://www.w3.org/2001/XMLSchema#string

Luis F Quintana

http://www.w3.org/2001/XMLSchema#string

Maria P Alcolea

http://www.w3.org/2001/XMLSchema#string

Pedro R Cutillas

http://www.w3.org/2001/XMLSchema#string

P2860

Cluster analysis and display of genome-wide expression patterns

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

Mass spectrometry-based proteomics turns quantitative

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition.

Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States.

Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: analysis of phosphoprotein dynamics in a B cell lymphoma cell line.

The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins.

Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control.

Chronic allograft nephropathy: An update.

P304

1658-1673

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M900059-MCP200

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19357086

http://www.w3.org/2001/XMLSchema#string

P921

P932

2709192

http://www.w3.org/2001/XMLSchema#string